歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Autophagy
產(chǎn)品編號(hào) 圖片 產(chǎn)品描述 分子式 加入購(gòu)物車(chē)

S81496

PH-797804       PH-797804,98%       C22H19BrF2N2O3

價(jià)格庫(kù)存

S80825

TWS119       TWS119,98%       C18H14N4O2

價(jià)格庫(kù)存

S80831

MEK162 (ARRY-162, ARRY-438162)       MEK162 (ARRY-162, ARRY-438162),98%       C17H15BrF2N4O3

價(jià)格庫(kù)存

S81504

Turofexorate isopropyl       Turofexorate isopropyl,99%       C25H24F2N2O3

價(jià)格庫(kù)存

S80862

AS-605240       AS-605240,98%       C12H7N3O2S

價(jià)格庫(kù)存

S80916

STF-31       STF-31,98%       C23H25N3O3S

價(jià)格庫(kù)存

S80917

Pirarubicin       Pirarubicin,99%       C32H37NO12

價(jià)格庫(kù)存

S80931

VX-702       VX-702,99%       C19H12F4N4O2

價(jià)格庫(kù)存

S80941

Isradipine       Isradipine,99%       C19H21N3O5

價(jià)格庫(kù)存

S80959

PHA-848125       PHA-848125,98%       C25H32N8O

價(jià)格庫(kù)存

S80993

BIIB021       BIIB021,98%       C14H15ClN6O

價(jià)格庫(kù)存

S81045

Ivacaftor (VX-770)       Ivacaftor (VX-770),99%       C24H28N2O3

價(jià)格庫(kù)存

S81046

IKK-16 (IKK Inhibitor VII)       IKK-16 (IKK Inhibitor VII),99%       C28H29N5OS

價(jià)格庫(kù)存

S81056

Vismodegib (GDC-0449)       Vismodegib (GDC-0449),99%       C19H14Cl2N2O3S

價(jià)格庫(kù)存

S81062

CCT128930       CCT128930,98%       C18H20ClN5

價(jià)格庫(kù)存

S81562

Enzalutamide       Enzalutamide,99%       C21H16F4N4O2S

價(jià)格庫(kù)存

S81123

Oprozomib (ONX 0912)       Oprozomib (ONX 0912),99%       C25H32N4O7S

價(jià)格庫(kù)存

S81128

VX-809 (Lumacaftor)       VX-809 (Lumacaftor),99%       C24H18F2N2O5

價(jià)格庫(kù)存

S81129

OSI-027       OSI-027,98%       C21H22N6O3

價(jià)格庫(kù)存

S81130

GSK690693       GSK690693,≥98%       C21H27N7O3

價(jià)格庫(kù)存

S81175

Cisatracurium Besylate       Cisatracurium Besylate,98%       C53H72N2O12·2C6H5O3S

價(jià)格庫(kù)存

S81179

Latrepirdine       Latrepirdine,≥96%       C21H25N3·2HCl

價(jià)格庫(kù)存

S81692

PF-04457845       PF-04457845,≥98%       C23H20F3N5O2

價(jià)格庫(kù)存

總計(jì) 100 個(gè)記錄 [1] [2] [3] [4] 5 [6] [7] [8] [9] [10]